Efficacy News and Research

RSS

Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia

Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced positive results from Trial CL-05, the second of two pivotal phase III clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day oral antibiotic for the treatment of mild-to-moderate community acquired pneumonia (CAP), the sixth leading cause of death in the United States.

16 Nov 2007

Freeze-dried grape powder blocks genes linked to colon cancer

Low doses of freeze-dried grape powder inhibit genes linked to the development of sporadic colorectal cancer, University of California, Irvine cancer researchers found.

15 Nov 2007

number of cases of most vaccine-preventable diseases is at an all-time low

A comparison of illness and death rates for 13 vaccine-preventable diseases in the U.S., before and after use of the vaccine, indicates there have been significant decreases in the number of cases, hospitalizations and deaths for each of the diseases examined, according to a study in the November 14 issue of JAMA: The Journal of the American Medical Association.

14 Nov 2007

Exercise and education improves function and symptoms in women with fibromyalgia

An exercise program that incorporates walking, strength training and stretching may improve daily function and alleviate symptoms in women with fibromyalgia, according to a report in the November 12, 2007 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Nov 2007

Back pain often over-treated

The Sydney University researchers, led by Mark Hancock from the University of Sydney Back Pain Research Group, followed 240 patients suffering from acute low back pain from their first visit to their GP through to recovery.

13 Nov 2007

Human Genome Sciences announces positive phase 2 LymphoStat-B results

Human Genome Sciences, Inc. has announced the presentation of Phase 2 clinical results demonstrating that LymphoStat-B (belimumab) achieved a sustained improvement in disease activity across multiple clinical measures, decreased the frequency of disease flares over time, and was well tolerated through 2.5 years on treatment in combination with standard of care in patients with active systemic lupus erythematosus (SLE).

13 Nov 2007

New guidelines on non-muscle invasive bladder cancer

The AUA is pleased to announce their new Guideline on the Management of Nonmuscle Invasive Bladder Cancer. Each year, more than 60,000 people are diagnosed with bladder cancer, which has been linked to a number of risk factors, including cigarette smoking and exposure to hazardous chemicals.

13 Nov 2007

Potential block buster on the horizon - new vaccine to control high blood pressure

A vaccine that would help people control their blood pressure is showing promise in early trials.

7 Nov 2007

D-cycloserine could help treat drug addiction

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory provide further evidence that a drug known as D-cycloserine could play a role in helping to extinguish the craving behaviors associated with drug addiction.

6 Nov 2007

Bavarian Nordic updates on vaccine project pipeline

In a business update, Danish-based biopharmaceutical company Bavarian Nordic, reported a number of developments in its vaccine project pipeline.

6 Nov 2007

Antibiotic that appears to control phobias may also be useful in treating addiction

6 Nov 2007

Zambia Medical Association calls for collaboration on HIV/AIDS research between doctors, herbalists

Conventional doctors and traditional herbalists in Zambia must collaborate on quality research for potential HIV/AIDS treatments to help reduce the spread of HIV/AIDS in the country, Zambia Medical Association President Swebby Macha said recently, Xinhua News Agency reports.

6 Nov 2007

Stereotaxis announces first atrial fibrillation procedures performed with performed with magnetic irrigated catheter

Stereotaxis, Inc. has announced that the first atrial fibrillation procedures performed with its partnered magnetic irrigated catheter were successfully completed over the course of the past week.

6 Nov 2007

New strategy for translational research creates new arrangements for clinical trials

The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a new joint arrangement for clinical trials. The initiative forms a key part of the developing MRC- NIHR joint strategy for translational research.

5 Nov 2007

New investigational combination pill improves multiple cholesterol disorders

Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.

5 Nov 2007

Antibody might help starve cancerous tumors

An antibody might offer a safe and effective complement to anti-cancer therapies designed to starve malignant tumors by pruning the blood vessels that feed them, researchers report in the November 2 issue of the journal Cell, a publication of Cell Press.

2 Nov 2007

Studies attribute recent increase in multiple myeloma survival to novel therapies

Multiple myeloma is one of the most common and devastating bone marrow cancers in the U.S., but survival rates have risen dramatically over the past decade.

2 Nov 2007

Enzyme sphingosine kinase 2 show to be potential new target to fight cancer

Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.

2 Nov 2007

Bevacizumab improves ovarian cancer treatment

A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.

1 Nov 2007

Research programme for foods and services promoting well-being

One of the challenges facing the food industry is how to create tasty, convenient and experiential products made from health promoting ingredients.

31 Oct 2007

Efficacy News and Research

Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia

Freeze-dried grape powder blocks genes linked to colon cancer

number of cases of most vaccine-preventable diseases is at an all-time low

Exercise and education improves function and symptoms in women with fibromyalgia

Back pain often over-treated

Human Genome Sciences announces positive phase 2 LymphoStat-B results

New guidelines on non-muscle invasive bladder cancer

Potential block buster on the horizon - new vaccine to control high blood pressure

D-cycloserine could help treat drug addiction

Bavarian Nordic updates on vaccine project pipeline

Antibiotic that appears to control phobias may also be useful in treating addiction

Zambia Medical Association calls for collaboration on HIV/AIDS research between doctors, herbalists

Stereotaxis announces first atrial fibrillation procedures performed with performed with magnetic irrigated catheter

New strategy for translational research creates new arrangements for clinical trials

New investigational combination pill improves multiple cholesterol disorders

Antibody might help starve cancerous tumors

Studies attribute recent increase in multiple myeloma survival to novel therapies

Enzyme sphingosine kinase 2 show to be potential new target to fight cancer

Bevacizumab improves ovarian cancer treatment

Research programme for foods and services promoting well-being

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News